Bayer Co.Lab

🧬 Every great idea starts with a single brick Our LEGO helix is a symbol of how we bring brilliant ideas to life. As we all have a role to play in architecting Berlin’s biotech future, attendees all contributed to this collaborative sculpture, during the Grand Opening of our brand-new Bayer Co.Lab in #Berlin. What’s the key brick to drive innovation forward? Share your thoughts in the comments – because great ideas are built together. 💡

Welcome MyoPax, the first #startup company at Bayer Co.Lab #Berlin! MyoPax is specialized in stem cell and gene editing technologies to develop muscle regeneration therapies. We look forward to supporting you in bringing your brilliant idea to life. 💡 #BayerCoLab #TeamBayer #cellandgenetherapy

🌟 Welcome Bayer Co.Lab Berlin! 🌟    Today, join us in celebrating the grand opening of Bayer Co.Lab #Berlin! We opened the doors to our brand-new facility with Stefan Oelrich, Member of the Board of Management of Bayer AG and Head of Bayer | Pharmaceuticals, the Governing Mayor of Berlin, Kai Wegner (Senatskanzlei Berlin), special guests, and announced our 1st tenant, MyoPax! Welcome to the Bayer Co.Lab community – we are thrilled to have you on board!🎉    Bayer Co.Lab Berlin serves as a launchpad for Europe's top scientists and #entrepreneurs and is a gateway for innovators from around the globe. Our mission is to empower #startups, particularly in the fields of #cellandgenetherapy and #oncology. Read more: https://lnkd.in/en8rQFaU   Are you a startup looking to elevate your company to the next level? Join us at Bayer Co.Lab Berlin, where we are bringing your brilliant ideas to life. https://lnkd.in/eqij68Pe #BayerCoLab #Innovation #Biotech #TeamBayer

🌟 1 more day! 🌟 Tomorrow is the Bayer Co.Lab #Berlin grand opening! Stay tuned for updates. As part of the Bayer Co.Lab network, Berlin becomes our fourth strategic location, right on the Bayer | Pharmaceuticals HQ. Alongside our Bayer Co.Lab locations in the USA, China, and Japan, this reflects our mission to promote scientific progress for patients worldwide.   If you're a #startup focused on cell and gene therapy or oncology, we invite you to join our vibrant ecosystem: https://lnkd.in/eqij68Pe #BayerCoLab #LifeSciences #Innovation #Entrepreneurship #TeamBayer

Wow, congrats to all the teams on the Sifted list! So great to see so many STATION F companies, including Aria, Kinetix, Greenly | Certified B Corp, Beev, Zenride, Sekoia.io, WhiteLab Genomics, WeWard & BuyCo :)

🌟 How It Started 🌟    Check out the early stages of Bayer Co.Lab #Berlin. Curious to see how it’s going? Stay tuned for our grand opening on November 28! 🎉   If you're a #startup focused on cell and gene therapy or #oncology, join our Bayer Co.Lab vibrant ecosystem. You will be part of a community of #entrepreneurs with opportunities to grow your company while bringing your brilliant ideas to life. (Link in the comments ⬇️). #BayerCoLab #TeamBayer

I had a great time Investival Showcase in London this week, meeting new people, connecting with old colleagues and presenting Bayer Co.Lab. Congratulations again to DISCO Pharmaceuticals GmbH on winning the prize for seed raise of the year at the European #lifestarsawards! It was an honour to present you your prize. Our brand new incubator for life science startups in Berlin is launching next week! Watch this space for more information, and reach out for collaborations. We are accepting tenancy applications, in particular in the areas of #cellandgenetherapy and/or #oncology LSX - partnering for Life Science eXecutives #BayerCoLab #innovation #startups #collaboration #CGT #biotech #lifesciences

🌟 WhiteLab Genomics Named One of France’s Top 50 Fastest-Growing Startups by Sifted! 🌟   This milestone is a direct reflection of the dedication and passion of our incredible team, as well as the trust of our clients and partners who believe in our mission to revolutionize genomic medicine. By powering our unique datasets and platform blending AI with cutting-edge biological insights, we’re pushing the boundaries of what’s possible and empowering researchers to develop breakthrough treatments that will shape the future of healthcare.  A huge thank you to everyone who has been part of our journey so far. We’re only getting started, and there’s so much more to come! Stay tuned. 🚀 #AI #genomicmedicine #growth #TechBio Y Combinator STATION F #Future40 Genopole Future4Care EIT Health Future4Care Bayer Co.Lab Omnes Debiopharm Laurent van Lerberghe Jean Pascal Tranie

We are thrilled to announce our newest Co.Lab Cambridge residency, Amplifyer Bio!   Led by the visionary Eric Huang and an exceptional team of co-founders—Maria Carmen Martin Alonso, PhD , Sangeeta Bhatia, Todd Golub, J. Christopher Love, and Viktor Adalsteinsson—Amplifyer is on a mission to revolutionize cancer diagnostics.   Their innovative approach focuses on developing novel priming agents that, when combined with current liquid biopsy diagnostics, will significantly enhance test performance. Amplifyer’s inaugural program aims to increase circulating free DNA (cfDNA) in blood, providing physicians and patients with a richer quantity and quality of genomic information related to cancer. This advancement has the potential to improve clinical outcomes and empower patients in their healthcare journey.   Join us in welcoming Amplifyer to the Bayer Co.Lab community!

Thank you to Berlin Partners for the opportunity to showcase the Boston-Cambridge ecosystem and how Bayer and Bayer Co.Lab can be the bridge between our communities.